DK382089A - Benzamidderivater - Google Patents

Benzamidderivater Download PDF

Info

Publication number
DK382089A
DK382089A DK382089A DK382089A DK382089A DK 382089 A DK382089 A DK 382089A DK 382089 A DK382089 A DK 382089A DK 382089 A DK382089 A DK 382089A DK 382089 A DK382089 A DK 382089A
Authority
DK
Denmark
Prior art keywords
chem
general formula
alkyl
amino
phenyl ring
Prior art date
Application number
DK382089A
Other languages
English (en)
Other versions
DK382089D0 (da
Inventor
Robert John Naylor
Brenda Naylor
Alain Renaud
Michel Langlois
Original Assignee
Robins Co Inc A H
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H, Delalande Sa filed Critical Robins Co Inc A H
Publication of DK382089D0 publication Critical patent/DK382089D0/da
Publication of DK382089A publication Critical patent/DK382089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK382089A 1988-08-04 1989-08-03 Benzamidderivater DK382089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402042A EP0353372B1 (en) 1988-08-04 1988-08-04 Antischizophrenic-S-N-(1-azabicyclo[2.2.2.]oct-3-yl) benzamides and thiobenzamides

Publications (2)

Publication Number Publication Date
DK382089D0 DK382089D0 (da) 1989-08-03
DK382089A true DK382089A (da) 1990-02-05

Family

ID=8200415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK382089A DK382089A (da) 1988-08-04 1989-08-03 Benzamidderivater

Country Status (11)

Country Link
US (1) US5025022A (da)
EP (1) EP0353372B1 (da)
JP (1) JPH02104529A (da)
KR (1) KR900002777A (da)
AT (1) ATE85217T1 (da)
AU (1) AU615323B2 (da)
DE (1) DE3878235T2 (da)
DK (1) DK382089A (da)
IL (1) IL91217A0 (da)
PH (1) PH25426A (da)
ZA (1) ZA895842B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353371A1 (en) * 1988-08-04 1990-02-07 Synthelabo Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002016358A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
AU2001284646A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
MXPA04004464A (es) * 2001-11-08 2004-08-11 Upjohn Co Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
AU2003214936A1 (en) * 2002-02-20 2003-09-09 Pharmacia And Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
US7176198B2 (en) 2002-08-01 2007-02-13 Pfizer Inc. 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
GB0310867D0 (en) 2003-05-12 2003-06-18 Novartis Ag Organic compounds
JP5775819B2 (ja) 2008-10-09 2015-09-09 ハワード ヒューズ メディカル インスティチュート 新規なキメラリガンド開口型イオンチャネルおよびその使用方法
MA37975B2 (fr) * 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
CN104418851A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 奎宁环衍生物的制备方法及纯化方法
TW202220648A (zh) 2020-07-24 2022-06-01 美商健臻公司 包含芬谷司他(venglustat)之醫藥組合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
GB8515845D0 (en) * 1985-06-22 1985-07-24 Beecham Group Plc Treatment
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
ES2051753T3 (es) * 1986-12-16 1994-07-01 Robins Co Inc A H N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
US4857517A (en) * 1988-02-04 1989-08-15 Rorer Pharmaceutical Corporation Quinuclidyl benzoxepins as 5-HT3 antagonists
EP0353371A1 (en) * 1988-08-04 1990-02-07 Synthelabo Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides

Also Published As

Publication number Publication date
DK382089D0 (da) 1989-08-03
PH25426A (en) 1991-07-01
EP0353372A1 (en) 1990-02-07
DE3878235D1 (de) 1993-03-18
DE3878235T2 (de) 1993-06-03
ATE85217T1 (de) 1993-02-15
KR900002777A (ko) 1990-03-23
IL91217A0 (en) 1990-07-12
AU615323B2 (en) 1991-09-26
US5025022A (en) 1991-06-18
EP0353372B1 (en) 1993-02-03
JPH02104529A (ja) 1990-04-17
AU3917889A (en) 1990-02-08
ZA895842B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
DK382089A (da) Benzamidderivater
NO942452L (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ATE172463T1 (de) Pyrrolocarbazol
FI900461A0 (fi) Imidazopyridaziner, deras framstaellning och anvaendning.
NO940831L (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
AU635445B2 (en) New compounds
DK0506434T3 (da) Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
DK492688A (da) Anvendelse af benzamider
IE893211L (en) Benzoxazepinone Process
DE68927554D1 (de) Cephalosporinverbindungen und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment